학술논문
Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view
Document Type
Article
Author
Source
In: European Journal of Haematology . (European Journal of Haematology, 1 August 2020, 105(2):203-215)
Subject
Language
English
ISSN
16000609
09024441
09024441